Skip to main content
CERS
NASDAQ Industrial Applications And Services

Cerus Secures Up To $110M New Debt Facility to Boost Liquidity and Refinance Existing Loans

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$2.6
Mkt Cap
$520.959M
52W Low
$1.15
52W High
$3.15
52W Position info
126% above low
Off High info
17% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

CERS has more than doubled off its 52-week low of $1.15.

Summary

Cerus Corporation has secured a new debt facility of up to $110 million, comprising a term loan and a revolving credit line, to enhance liquidity and refinance existing debt. This financing is critical for the company's operational stability and runway, especially given recent reports of increased cash burn.


Key Events · Financing and Capital Events · CERS

  • New Debt Facility Secured

    Cerus entered into new credit agreements for a term loan facility of up to $65.0 million and a revolving credit facility of up to $30.0 million, expandable to $45.0 million.

  • Refinancing and Liquidity Boost

    The company drew $35.0 million from the term loan, using $30.0 million to refinance existing debt, resulting in an initial net $5.0 million cash injection, with an additional $30.0 million term loan available. The revolving facility had $29.9 million outstanding at closing.

  • Extended Financial Runway

    This new financing provides substantial capital, addressing the company's increased operating cash burn and commencing debt amortization, as noted in its recent Q1 2026 financial report.

  • Secured by Assets and Covenants

    The obligations under the new credit agreements are secured by substantially all of the company's assets and include customary financial covenants, such as minimum net revenue requirements.


Analysis · CERS · Industrial Applications And Services

This 8-K details the new debt facility, which provides significant capital to Cerus Corporation. The facility, totaling up to $110 million, includes a term loan and a revolving credit line. This financing is crucial for extending the company's operational runway and addressing its previously reported increased operating cash burn and commencing debt amortization. While it increases leverage, it secures necessary liquidity for general corporate purposes and refinancing existing debt.

At the time of this filing, CERS was trading at $2.60 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $521M. The 52-week trading range was $1.15 to $3.15. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CERS - Latest Insights

CERS
Jun 08, 2026, 8:42 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.71
Real-time Price: $2.89 info
Change: +$0.180 (+7%) info
Market Cap: $575.059M info
CERS
Jun 03, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.66
Real-time Price: $2.89 info
Change: +$0.230 (+9%) info
Market Cap: $575.059M info
CERS
May 27, 2026, 12:52 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.82
Real-time Price: $2.89 info
Change: +$0.070 (+2%) info
Market Cap: $575.059M info
CERS
Apr 30, 2026, 5:05 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.16
Real-time Price: $2.89 info
Change: +$0.730 (+34%) info
Market Cap: $575.059M info
CERS
Apr 30, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.25
Real-time Price: $2.89 info
Change: +$0.640 (+28%) info
Market Cap: $575.059M info